Skip to main content
. 2016 Feb 12;7(11):13013–13030. doi: 10.18632/oncotarget.7344

Figure 1. Kaplan-Meier survival analyses of the patient cohort and subgroups.

Figure 1

Overall a. and disease free survival b. were analyzed for the complete patient cohort (left panels). Subgroup analyses were performed for patients with high risk disease (middle panels) or with precursor B-ALL only (right panels). Log rank analyses comparing patients with HER2/neu+ and HER2/neu ALL are provided.